You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SC Peginterferon beta-1a

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Female Participants Exposed to Subcutaneous Peginterferon

Completed
  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • Interferon Beta Therapy
  • Göttingen, Germany
    Research Site
Nov 1, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Dimethyl Fumarate, Peginterferon Beta-1a, Placebo)

Terminated
  • Multiple Sclerosis, Relapsing-Remitting
  • Dimethyl Fumarate
  • +2 more
  • Raleigh, North Carolina
  • +22 more
Nov 30, 2022

Relapsing Remitting Multiple Sclerosis (RRMS) Trial in Tehran (Pegylated interferon beta-1a, Interferon Beta-1A Prefilled

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis (RRMS)
  • Pegylated interferon beta-1a
  • Interferon Beta-1A Prefilled Syringe
  • Tehran, Iran, Islamic Republic of
    Sina Hospital
Feb 5, 2022

Healthy Subjects, Pharmacokinetics, Pharmacodynamics Trial in West Bend (Interferon beta-1a, Peginterferon beta-1a, Placebo)

Completed
  • Healthy Subjects
  • +2 more
  • Interferon beta-1a
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Aug 16, 2021

MS (Multiple Sclerosis), Erythema Trial in Kirkland (Warm Compress Before Injection, Cold Compress After Injection)

Completed
  • MS (Multiple Sclerosis)
  • Erythema
  • Warm Compress Before Injection
  • Cold Compress After Injection
  • Kirkland, Washington
    Evergreen Health
Mar 10, 2022

Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate

Recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +8 more
  • Eden Prairie, Minnesota
    OptumInsight
Jan 9, 2023

Multiple Sclerosis Trial in Cairo (Blood sample collection)

Recruiting
  • Multiple Sclerosis
  • Blood sample collection
  • Cairo, Egypt
    Nasser Institute for Research and Treatment
Feb 21, 2023

Sars-CoV-2 Infection Trial in Baltimore (Peginterferon lambda alfa-1a subcutaneous injection, Saline)

Terminated
Has Results
  • Sars-CoV-2 Infection
  • Peginterferon lambda alfa-1a subcutaneous injection
  • Saline
  • Baltimore, Maryland
    Johns Hopkins Hospital
Jul 12, 2022

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

Not yet recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +5 more
  • Interferon Beta-1A
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

Covid19 Trial in United States (IFN beta-1a, Dexamethasone)

Terminated
Has Results
  • Covid19
  • Aurora, Colorado
  • +3 more
Oct 13, 2022

Herpes Zoster Trial (Peginterferon a1b, Peginterferon a1b with valacyclovir, Valacyclovir)

Not yet recruiting
  • Herpes Zoster
  • Peginterferon α1b
  • +2 more
  • (no location specified)
Aug 5, 2022

Interferon Beta Therapy in Participants With Multiple Sclerosis

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • SC Peginterferon beta-1a
  • +2 more
  • Göttingen, Germany
    Research Site
Sep 24, 2019

Bioequivalence Trial in Tempe, Lincoln (efgartigimod PH20 SC as a prefilled syringe presentation, efgartigimod PH20 SC as a vial

Recruiting
  • Bioequivalence
  • efgartigimod PH20 SC as a prefilled syringe presentation
  • efgartigimod PH20 SC as a vial + syringe presentation
  • Tempe, Arizona
  • +1 more
Apr 5, 2023

COVID-19 Trial in Stanford (Peginterferon Lambda-1a, Placebo)

Completed
Has Results
  • COVID-19
  • Peginterferon Lambda-1a
  • Placebo
  • Stanford, California
    Stanford University School of Medicine
Nov 24, 2021

Multiple Sclerosis Trial in Shreveport (Interferon beta 1a, oral doxycycline)

Completed
Has Results
  • Multiple Sclerosis
  • Interferon beta 1a, oral doxycycline
  • Shreveport, Louisiana
    LSU Health Sciences Center Shreveport
Oct 11, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States

Suspended
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Los Angeles, California
  • +5 more
Dec 10, 2022

Lactose Intolerance Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2 beta-casein)

Recruiting
  • Lactose Intolerance
  • Milk containing A1 and A2 beta-casein
  • Milk containing only A2 beta-casein
  • West Lafayette, Indiana
    Purdue University
Dec 20, 2022

Lactose Intolerance, Adult Type Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2

Active, not recruiting
  • Lactose Intolerance, Adult Type
  • Milk containing A1 and A2 beta-casein
  • Milk containing only A2 beta-casein
  • West Lafayette, Indiana
    Purdue MRI Facility
Dec 17, 2022

Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)

Recruiting
  • Alzheimer Disease
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Nov 17, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Birmingham, Alabama
  • +8 more
Jan 24, 2023

NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Tislelizumab IV
  • +2 more
  • (no location specified)
Oct 25, 2023

Sars-CoV2, Covid19 Trial in Toronto (Peginterferon Lambda-1A, Placebo)

Active, not recruiting
  • Sars-CoV2
  • Covid19
  • Peginterferon Lambda-1A
  • Placebo
  • Toronto, Ontario, Canada
    Toronto General Hospital
Apr 4, 2022

Relapsing Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Ocrelizumab-matching , Ocrelizumab)

Active, not recruiting
Has Results
  • Relapsing Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Phoenix, Arizona
  • +140 more
Jan 2, 2023

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

Lactose Intolerance Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2 beta-casein)

Recruiting
  • Lactose Intolerance
  • Milk containing A1 and A2 beta-casein
  • Milk containing only A2 beta-casein
  • West Lafayette, Indiana
    Purdue University
Dec 20, 2022